Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Back to basics: What is semaglutide
Retatrutide is an investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, distinguishing it from semaglutide and tirzepatide
Compounded medications are not FDA-approved as finished products Pricing structures vary by platform and program type Availability varies by state based on federal and state compounding regulations Cash-pay models typically do not involve insurance MyStart Health Program Information According to publicly available information on the MyStart Health website, the platform lists cash-pay pricing tiers for compounded tirzepatide programs
Psychol Med 2014
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 28.55
US$ 28.86
US$ 24.67
US$ 25.07
